Experience the Clinical and Economic Benefits of Bardex® I.C. Infection Control Foley Catheter Systems |
 |
Urinary tract infections (UTIs) present a serious and costly health issue that is commanding the attention of clinicians and hospital administrators everywhere. UTIs account for approximately 40% of all healthcare-associated infection; 80% of these infections are related to Foley catheters. Catheter-associated urinary tract infections (CAUTIs) affect thousands of patients each year and are associated with increased morbidity, mortality, and cost.
The occurrence of urinary tract infection is 3.7 times greater in patients catheterized with a standard catheter than in patients catheterized with the Bardex® I.C. Foley catheter with Bacti-Guard®* silver alloy coating and Bard® hydrogel (95 C.I. 2.0-6.8).
By using Bardex® I.C. anti-infective Foley catheters utilizing Bacti-Guard®* silver alloy coating and Bard® hydrogel, hospitals have been able to realize economic benefits through the reduction of CAUTIs.
Infection Control Technology
Bardex® I.C. anti-infective Foley catheters harness the anti-infective properties of a precise balance of gold, palladium and silver to inhibit formation of biofilm, while also preventing trauma to urethral cells, thus avoiding a precursor to infection. An optimal balance of the Bacti-Guard®* silver alloy and Bard® hydrogel ensures efficacy without compromising patient safety. The coating is engineered to a precise balance that maximizes the bacteriostatic action while minimizing any risk of toxicity. In addition to preventing bacterial adherence, this technology is designed to inhibit migration of pathogens into the bladder and preserve the integrity of the urethral mucosa.
Proven Results
Contact your local sales representative for copies of these clinical studies supporting the use of Bardex® I.C. Foley Catheter Systems.
- A Randomized Crossover Study of Silver-Coated Urinary Catheters in Hospitalized Patients
Karchmer, Giannetta, Muto, Strain, Farr, Archives of Internal Medicine, 2000;160: 3294-3298 - Effect of Silver-Coated Urinary Catheters: Efficacy, Cost-Effectiveness, and Antimicrobial Resistance
Rupp, Fitzgerald, Marion, Helget, Puumala, Anderson, Fey, American Journal of Infection Control, 2004; 32(8): 445-450 - What practices will most improve safety? Evidence-based medicine meets patient safety
Leape, Berwick, Bates, Journal of the American Medical Association, 2002; 288(4): 501-507 - Engineering out the risk for infection with urinary catheters
Maki, Tambyah, Emerging Infectious Diseases, 2001; 7(2): 342-347 - Hospital-onset infections: a patient safety issue
Gerberding, Annals of Internal Medicine, 2002; 137(8): 665-670 - The Efficacy of Silver Alloy-Coated Urinary Catheters in Preventing Urinary Tract Infections: A Meta-Analysis
Saint, Elmore, Sullivan, Emerson, Koepsell, American Journal of Medicine, 1998; 105: 236-241 - The potential clinical and economic benefits of silver alloy urinary catheters in preventing urinary tract infection
Saint, Veenstra, Sullivan, Chenoweth, Fendrick, Archives of Internal Medicine, 2000; 160: 2670-2675
Economic Benefits
Bardex I.C. Foley Catheter Systems help hospitals achieve clinical goals while providing economic benefits. By reducing the occurrence of CAUTIs you also reduce expenditures associated with:
- Lab & diagnostic tests
- Antibiotics
- Physician consults
- Un-reimbursed room & care charges